IL6 and age-related macular degeneration: IL-6 has emerged as a key molecular mediator in this process, with systemic levels significantly elevated in late-stage age-related macular degeneration (AMD), including geographic atrophy and neovascular subtypes, while showing only marginal association with early AMD (Nahavandipour et al., 2020; Yadav et al., 2024).